The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Top Cited Papers
- 30 June 2011
- journal article
- review article
- Published by Elsevier BV in Trends in Biochemical Sciences
- Vol. 36 (6), 320-328
- https://doi.org/10.1016/j.tibs.2011.03.006
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3KCancer Cell, 2010
- Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and StressMolecular Cell, 2010
- 4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in TumorsCancer Cell, 2010
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- KSR2 Is an Essential Regulator of AMP Kinase, Energy Expenditure, and Insulin SensitivityCell Metabolism, 2009
- The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK–ERK pathway to late endosomesThe EMBO Journal, 2009
- Ran-Binding Protein 3 Phosphorylation Links the Ras and PI3-Kinase Pathways to Nucleocytoplasmic TransportMolecular Cell, 2008
- Mitogenic signaling pathways induced by G protein‐coupled receptorsJournal of Cellular Physiology, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Phosphatidylinositol-3-OH kinase direct target of RasNature, 1994